Thomas Zeller (Germany) answers the following questions :
- Why come to RHC 2014 in Berlin, next February?
- Why is a pharmacology-oriented session important for the participants?
Relive the course with B.
Why attend RHC: the vision of the Board
Effective management of hypertensive patients is associated with a reduction in cardiovascular mortality, stroke and myocardial infarction.
For all hypertensive patients, the normalisation of arterial blood pressure is the main objective of management strategy.
Yet, despite the prescription of combinations of ≥ 3 different antihypertensive drugs, in certain patient populations this objective is not achieved.
The Resistant Hypertension Course (“RHC”) Board is pleased to announce that Costas Tsioufis (Assistant Professor of Cardiology, University of Athens, Chief of Hypertension Unit, First Cardiology Clinic, University of Athens, Greece) is joining Felix Mahfoud as Co-Chairperson of the RHC 2014. Costas Tsioufis will represent the European Society of Hypertension, where he currently holds the position of Secretary.